Bladder Cancer Clinical Trials | Norton Healthcare Louisville, Ky.

Bladder Cancer and Urothelial Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments and numerous bladder cancer clinical trials.

Learn more about participating in a clinical trial at Norton Healthcare.

Active bladder cancer and urothelial cancer clinical trials include:

Advanced Solid Tumors

A Phase 1 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of Escalating Doses Of Pf-06939999 (Prmt5 Inhibitor) In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer, Head And Neck Squamous Cell Carcinoma, Esophageal […]

Bladder Cancer

A Phase 3 Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations

Bladder Cancer

A Phase Ib/II Open Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Locally Advanced Or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy (MORPHEUS-mUC)

Bladder Cancer

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

Bladder Cancer

A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin for Neoadjuvant Treatment Followed by Durvalumab Alone for Adjuvant Treatment in Patients with Muscle-Invasive Bladder […]

Bladder Cancer

A Phase III, Randomized, Open Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab a

Bladder Cancer

A Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer after Failure of Platinum-Based Regimen or Anti-PD-1/ PD-L1 Based Immunotherapy

Bladder Cancer

A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) versus CRT Alone in Participants with Muscle-invasive Bladder Cancer (MIBC) (KEYNOTE-992)

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3500

Celebrating cancer survivors and giving them a care plan for a long life

June 6 is National Cancer Survivors Day — a time to celebrate the strength and courage of survivors, their families and caregivers. It’s a good time to remember that life after cancer can be fulfilling, […]

Read Full Story

How to talk to your doctor about sex and cancer

Sexual health is important for any adult’s well-being, but patients with cancer face a new set of challenges when it comes to sexuality. Laila S. Agrawal, M.D., breast cancer oncologist with Norton Cancer Institute, is […]

Read Full Story

Pain in the front of your neck: When to worry

Pain in your neck to the side of your windpipe could be caused by many minor conditions such as a sore throat, swollen lymph nodes or muscle strains such as whiplash or from bending over […]

Read Full Story

CAR-T cell therapy triggers the body’s own defenses to fight cancer

CAR-T cell therapy takes advantage of the body’s immune system to fight off cancer, much like it does already to kick the common cold and other types of illness. Our bodies don’t always fight off […]

Read Full Story

Colonoscopy age dropping from 50 to 45 for most

The recommended age for colonoscopy and other colon cancer screenings is increasingly considered to be 45 for those at average risk, five years earlier than the previous guidance. The risk of developing colon cancer is […]

Read Full Story
Related Stories

Celebrating cancer survivors and giving them a care plan for a long life

June 6 is National Cancer Survivors Day — a time to celebrate the strength and courage of survivors, their families and caregivers. It’s a good time to remember that life after cancer can be fulfilling, […]

Read Full Story

How to talk to your doctor about sex and cancer

Sexual health is important for any adult’s well-being, but patients with cancer face a new set of challenges when it comes to sexuality. Laila S. Agrawal, M.D., breast cancer oncologist with Norton Cancer Institute, is […]

Read Full Story

Pain in the front of your neck: When to worry

Pain in your neck to the side of your windpipe could be caused by many minor conditions such as a sore throat, swollen lymph nodes or muscle strains such as whiplash or from bending over […]

Read Full Story

CAR-T cell therapy triggers the body’s own defenses to fight cancer

CAR-T cell therapy takes advantage of the body’s immune system to fight off cancer, much like it does already to kick the common cold and other types of illness. Our bodies don’t always fight off […]

Read Full Story

Colonoscopy age dropping from 50 to 45 for most

The recommended age for colonoscopy and other colon cancer screenings is increasingly considered to be 45 for those at average risk, five years earlier than the previous guidance. The risk of developing colon cancer is […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.